Fatal Airway Inflammation Induced by Pembrolizumab in a Patient With NSCLC

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.09.002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Inhibition of LPS-induced Airway Hyperresponsiveness and Airway Inflammation by LPS Antagonists

American Journal of Physiology - Lung Cellular and Molecular Physiology
PulmonaryRespiratory MedicinePhysiologyCell Biology
2001English

Neuropsychiatric Immune-Related Adverse Events Induced by Pembrolizumab in a Patient With Lung Adenocarcinoma and Systemic Lupus Erythematosus

Internal Medicine
Internal MedicineMedicine
2020English

Pembrolizumab-Induced Obstructive Bronchiolitis in a Patient With Stage IV Non-Small-Cell Lung Cancer

Current Oncology
Oncology
2019English

Markers of Airway Inflammation in Pulmonary Diseases Assessed by Induced Sputum

Monaldi Archives for Chest Disease
Cardiovascular MedicinePulmonaryRespiratory MedicineCardiology
2016English

Bilateral Vocal Cord Paralysis: Pembrolizumab-Induced Delayed-Onset Toxicity in a Patient With Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Pembrolizumab-Induced Sarcoid Granulomatous Panniculitis and Bullous Pemphigoid in a Single Patient

Clinical Case Reports
Medicine
2019English

Pembrolizumab‐induced Secondary Sclerosing Cholangitis in a Non‐small Cell Lung Cancer Patient

Respirology Case Reports
PulmonaryRespiratory Medicine
2020English

Role of TRPV1 in Inflammation-Induced Airway Hypersensitivity

Current Opinion in Pharmacology
Drug DiscoveryPharmacology
2009English

Fatal Myositis and Spontaneous Haematoma Induced by Combined Immune Checkpoint Inhibitor Treatment in a Patient With Pancreatic Adenocarcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy